Toggle navigation
COVID-19
About
About The ASCO Post
Editorial Board
Rights and Permissions
Contact
Subscribe
News
FDA Update
Journal Spotlight
Expert's Corner
In the Clinic
View By Issue
View All
Meetings
24th SUO Annual Meeting
2023 NCCN Annual Congress: Hematologic Malignancies
IASLC 2023 WCLC
2023 Global Cardio-Oncology Summit
2023 ASCO Quality Care Symposium
Calendar
View All
Topics
Breast Cancer
Lung Cancer
Prostate Cancer
Lymphoma
Cardio-oncology
View All
Videos
Newsreels
Video Roundtables
Podcasts
Subscribe
Advertisement
Advertisement
2019 ASH Annual Meeting
«
1
»
Advertisement
Advertisement
Dec
04
Today In Oncology
Disitamab Vedotin in Previously Treated Patients With Advanced HER2-Positive Urothelial Carcinoma
Adding Tiragolumab to Atezolizumab and Chemotherapy in Previously Untreated Extensive-Stage SCLC
Predicting Primary Ovarian Insufficiency in Childhood Cancer Survivors
FDA Grants Accelerated Approval to Pirtobrutinib for CLL/SLL
Black Men With Advanced Prostate Cancer May Be Less Likely to Receive Treatment
View More
Advertisement
